StonvexLoading…
StonvexStonvexStonvexCore line items from TGT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-05-02 | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 |
|---|---|---|---|---|
Revenue | $25.44B | $104.78B | $74.33B | $49.06B |
Operating Income | $1.14B | $5.12B | $3.74B | $2.79B |
Net Income | $781.00M | $1.05B | $689.00M | $935.00M |
EPS (Diluted) | $1.71 | $8.13 | $5.84 | $4.32 |
Total Assets | $58.01B | $59.49B | $59.99B | $57.85B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.53B | $5.49B | $3.82B | $4.34B |
Free Cash Flow OCF − CapEx | $-319.00M | $2.83B | $643.00M | $494.00M |
Shares Outstanding | 454.18M | 452.84M | 452.80M | 454.40M |